BioNTech SE
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.9% | +74.3% | +22.2% | +190.7% | +582.8% | +47.0% | -1.2% | -2.1% | -2.4% | |
| – | -40.4% | +136.7% | +24.8% | +197.6% | +804.2% | +45.4% | -10.9% | -3.7% | -14.2% | |
| – | -43.3% | +139.1% | +26.2% | +133.1% | +39.9% | +719.7% | -15.9% | -16.3% | -21.4% | |
| – | -43.5% | +138.9% | +26.5% | +158.7% | +53.9% | +578.0% | +17.7% | +1.4% | -11.6% | |
| – | -23.4% | +521.6% | -29.0% | +719.1% | +7,381.6% | -42.3% | -67.3% | -34.9% | -35.4% | |
| – | +18.7% | +49.4% | +102.5% | +446.8% | +683.9% | -12.5% | -18.6% | -20.8% | -60.9% | |
| – | – | +14.2% | +27.7% | +120.1% | +59.7% | – | – | – | – | |
| – | +0.0% | +0.0% | +457.7% | +1,703.2% | +7.6% | +5.9% | +492.3% | +5.0% | -3.4% | |
| – | +679.4% | +5.4% | -1.2% | +20.1% | +39.3% | +9.6% | +407.3% | -1.7% | +103.1% | |
| – | +18.1% | -8.7% | -21.2% | +211.3% | +315.8% | -18.1% | -14.4% | +13.0% | -11.4% | |
| – | +179.9% | -20.5% | +9.5% | +338.7% | +474.5% | -15.3% | -29.8% | +21.9% | -15.1% | |
| – | +538.2% | -67.8% | +22.1% | +19.4% | +1,327.5% | -72.3% | -21.9% | +40.6% | +32.1% | |
| – | +744.9% | -20.6% | -50.9% | +399.1% | +56.4% | +27.6% | +73.4% | +20.5% | +25.3% | |
| – | – | – | +1,130.4% | +235.3% | -25.7% | +2.7% | +8.4% | +12.4% | +0.2% | |
| – | -261.8% | – | +85.4% | +178.0% | +767.0% | +68.6% | +0.9% | -4.1% | -1.0% | |
| – | – | – | – | – | – | +90.6% | +4.9% | -3.4% | -6.0% | |
| – | – | +0.0% | -6.8% | +17.5% | +4.5% | -3.8% | -2.8% | -0.9% | +0.5% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.